Tuesday, June 14, 2022

Register to learn how using data-driven approaches to guide covariate adjustment – controlling for baseline patient variables to better estimate treatment effects – can improve clinical trials.

Key opinion leaders from Owkin, Bristol Myers Squibb, and CancerLinQ will discuss:

  • How covariate adjustment reduces noise in clinical trials, and the challenges of using traditional methods for covariate selection
  • The advantages machine learning and multimodal data bring to the covariate selection process
  • A pharma case study highlighting the impact of data-driven covariate selection on trial outcomes
  • How regulators' appetite for data-driven covariate adjustment is changing
Hosted by:
    BC_Owkin_2022.png
Register For Webinar
Fill out the form below to save your spot.
Moderator
Karen Tkach Tuzman, Ph.D.


Senior Editor, Head of Discovery & Preclinical Development

BioCentury

Panelists
Jean-Frédéric Petit-Nivard


Chief Commercial Officer

Owkin

Félix Balazard, Ph.D.


Lead Data Scientist

Owkin

David Paulucci


Director, Data Science

Bristol Myers Squibb

Sean Khozin, M.D.


Chief Executive Officer

CancerLinQ LLC & Executive Vice President, ASCO, Ex FDA